Add to ORKG13301甲第4589号博士（医学）金沢大学博士論文本文Full 以下に掲載：Oncotarget 8(14) pp.22811-22824 2017. Impactjournals. 共著者：古田 拓也, 淑瑠 ヘムラサビット, 董 宇, 宮下 勝吉, 木下 雅史, 内山 尚之, 林 康彦, 林 裕, 源 利成, 中田 光
BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP co...
###EgeUn###AIM: To investigate the apoptotic and molecular effects of glycogen synthase kinase-3 (GS...
<p><b><i>Introduction:</i></b> Glycogen synthase kinase 3α/β (GSK3α/β) is a serine/threonine kinase ...
Glioblastoma is the most malignant form of brain cancer. Due to its aggressive nature, extensive res...
Resistance to chemotherapy remains a major challenge in the treatment of human glioblastoma (GBM). G...
Studies in vitro and in animal model were carried out complementary to optimize treatment of gliobla...
Glioblastoma multiforme (GBM) is the most malignant form of brain cancer. Therapies targeting gliobl...
金沢大学がん研究所分子標的がん医療研究開発センターImprovement in the outcome of cancer patients who are refractory to current...
Glioblastoma (GBM) is the most common and aggressive malignant grade IV brain tumour. It remains an ...
Abstract AIMS GSK3β is a constitutively conserved serine/threonine kinase involved in a number of bi...
Glioblastoma multiforme (GBM), designated as World Health Organization (WHO) grade IV astrocytoma, i...
Introduction: Glycogen synthase kinase 3α/β (GSK3α/β) is a serine/threonine kinase that plays a crit...
13301甲第3924号博士（医学）金沢大学博士論文本文Full 以下に掲載：Carcinogenesis 34(10) pp.2206-2217 2013. Oxford University Pr...
Glioblastoma (GBM) is the most common high-grade brain tumor diagnosed in patients who are more than...
Glioblastoma (GBM) is the most common high-grade brain tumor diagnosed in patients who are more than...
BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP co...
###EgeUn###AIM: To investigate the apoptotic and molecular effects of glycogen synthase kinase-3 (GS...
<p><b><i>Introduction:</i></b> Glycogen synthase kinase 3α/β (GSK3α/β) is a serine/threonine kinase ...
Glioblastoma is the most malignant form of brain cancer. Due to its aggressive nature, extensive res...
Resistance to chemotherapy remains a major challenge in the treatment of human glioblastoma (GBM). G...
Studies in vitro and in animal model were carried out complementary to optimize treatment of gliobla...
Glioblastoma multiforme (GBM) is the most malignant form of brain cancer. Therapies targeting gliobl...
金沢大学がん研究所分子標的がん医療研究開発センターImprovement in the outcome of cancer patients who are refractory to current...
Glioblastoma (GBM) is the most common and aggressive malignant grade IV brain tumour. It remains an ...
Abstract AIMS GSK3β is a constitutively conserved serine/threonine kinase involved in a number of bi...
Glioblastoma multiforme (GBM), designated as World Health Organization (WHO) grade IV astrocytoma, i...
Introduction: Glycogen synthase kinase 3α/β (GSK3α/β) is a serine/threonine kinase that plays a crit...
13301甲第3924号博士（医学）金沢大学博士論文本文Full 以下に掲載：Carcinogenesis 34(10) pp.2206-2217 2013. Oxford University Pr...
Glioblastoma (GBM) is the most common high-grade brain tumor diagnosed in patients who are more than...
Glioblastoma (GBM) is the most common high-grade brain tumor diagnosed in patients who are more than...
BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP co...
###EgeUn###AIM: To investigate the apoptotic and molecular effects of glycogen synthase kinase-3 (GS...
<p><b><i>Introduction:</i></b> Glycogen synthase kinase 3α/β (GSK3α/β) is a serine/threonine kinase ...